Soligenix SNGX
NASDAQ SNGX
$0.37 +0.01 (+2.78%)
At close: Oct 2, 2026 · 4:00 PM EDT

Soligenix (SNGX) Selling, General & Administrative (2010 - 2026)

Updated

Soligenix's Selling, General & Administrative was $1.13 million in Q2 2026, up 3.5% from $1.09 million a year earlier and up 2.1% from the prior quarter.

Analysis

Soligenix (SNGX) Selling, General & Administrative (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Soligenix's Selling, General & Administrative was $4.42 million through Jun 30, 2026, up 7.1% year-over-year; for FY2025, it came in at $4.36 million, up 3.4% from FY2024.

  • Selling, General & Administrative shows a five-year compound annual growth rate of 0.1% (FY2020 to FY2025).
  • In earlier years, Selling, General & Administrative was $4.22 million in FY2024 (-5.9%), $4.48 million in FY2023 (-33.0%), $6.69 million in FY2022 (+33.6%) and $5.01 million in FY2021 (+15.7%).
  • Quarterly Selling, General & Administrative has moved between $890,533 (Q2 2023) and $2.54 million (Q1 2022) over five years.
  • Compared with a year earlier, Selling, General & Administrative has increased for four straight quarters, with an average decline of 1.1% over the last eight quarters.
  • The best year-over-year quarter for Selling, General & Administrative over five years was Q1 2022 (growth of 167.7%); the worst was Q1 2023 (a decline of 51.4%).
  • Per Business Quant data, SNGX's Selling, General & Administrative in the three quarters before Q2 2026 was $1.1 million (Q1 2026), $1.19 million (Q4 2025) and $996,604 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Soligenix 5.90 Mn 5.90 Mn - 1.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.13 Mn
Mar 31, 2026 1.10 Mn
Dec 31, 2025 1.19 Mn
Sep 30, 2025 996,604.00
Jun 30, 2025 1.09 Mn
Mar 31, 2025 1.08 Mn
Dec 31, 2024 1.05 Mn
Sep 30, 2024 896,547.00
Jun 30, 2024 1.24 Mn
Mar 31, 2024 1.02 Mn
Dec 31, 2023 1.38 Mn
Sep 30, 2023 973,040.00
Jun 30, 2023 890,533.00
Mar 31, 2023 1.24 Mn
Dec 31, 2022 1.44 Mn
Sep 30, 2022 1.33 Mn
Jun 30, 2022 1.38 Mn
Mar 31, 2022 2.54 Mn
Dec 31, 2021 1.85 Mn
Sep 30, 2021 1.15 Mn
API Access

Soligenix Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=SNGX&period=max&api_key=YOUR_API_KEY